Search Results

Return to List
Results 1–20 of 38
Sort By: Relevance | Date | Title

Access to Emergency Contraception

Committee Opinion Number 542, November 2012

ABSTRACT Emergency contraception includes contraceptive methods used to prevent pregnancy in the first few days after unprotected intercourse sexual assault or contraceptive failure Although the US Food and Drug Administration approved the first dedicated product for emergency contraception in 199...

November 2012

PDF Format

Analgesia and Cesarean Delivery Rates

Committee Opinion Number 339, June 2006

(Reaffirmed 2016, Replaces No. 269, February 2002)

ABSTRACT Neuraxial analgesia techniques are the most effective and least depressant treatments for labor pain The American College of Obstetricians and Gynecologists previously recommended that practitioners delay initiating epidural analgesia in nulliparous women until the cervical dilatation rea...

June 2006

PDF Format

Antenatal Corticosteroid Therapy for Fetal Maturation

Committee Opinion Number 677, October 2016

ABSTRACT Corticosteroid administration before anticipated preterm birth is one of the most important antenatal therapies available to improve newborn outcomes A single course of corticosteroids is recommended for pregnant women between 24 07 weeks and 33 67 weeks of gestation including for those w...

October 2016

PDF Format

Aromatase Inhibitors in Gynecologic Practice

Committee Opinion Number 663, June 2016

(Replaces Committee Opinion Number 412, August 2008)

ABSTRACT Aromatase inhibitors have been used for the treatment of breast cancer ovulation induction endometriosis and other estrogenmodulated conditions For women with breast cancer bone mineral density screening is recommended with longterm aromatase inhibitor use because of risk of osteoporosis ...

June 2016

PDF Format

Brand Versus Generic Oral Contraceptives

Committee Opinion Number 375, August 2007

(Reaffirmed 2015)

ABSTRACT The US Food and Drug Administration considers generic and brand name oral contraceptive OC products clinically equivalent and interchangeable The American College of Obstetricians and Gynecologists supports patient or clinician requests for branded OCs or continuation of the same generic ...

August 2007

PDF Format

Chronic Antithrombotic Therapy and Gynecologic Surgery

Committee Opinion Number 610, October 2014

ABSTRACT Surgery can present a management dilemma for gynecologists whose patients receive chronic antithrombotic therapy because the risk of hemorrhagic complications must be balanced against the risk of thromboembolic complications Interruption of antithrombotic therapy to reduce perioperative b...

October 2014

PDF Format

Compounded Bioidentical Menopausal Hormone Therapy

Committee Opinion Number 532, August 2012

(Reaffirmed 2016, Replaces No. 387, November 2007 and No. 322, November 2005)

ABSTRACT Although improvement in longterm health is no longer an indication for menopausal hormone therapy evidence supporting fewer adverse events in younger women combined with its high overall effectiveness has reinforced its usefulness for shortterm treatment of menopausal symptoms Menopausal ...

August 2012

PDF Format

Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period

Committee Opinion Number 623, February 2015

(Reaffirmed 2016. Replaces Committee Opinion Number 514, December 2011)

ABSTRACT Acuteonset severe systolic hypertension severe diastolic hypertension or both can occur in pregnant women or women in the postpartum period Introducing standardized evidencebased clinical guidelines for the management of patients with preeclampsia and eclampsia has been demonstrated to re...

February 2015

PDF Format

Ethical Issues in Pandemic Influenza Planning Concerning Pregnant Women

Committee Opinion Number 563, May 2013

(Reaffirmed 2016)

ABSTRACT Pregnant women traditionally have been assigned priority in the allocation of prevention and treatment resources during outbreaks of influenza because of their increased risk of morbidity and mortality The Committee on Ethics of the American College of Obstetricians and Gynecologists expl...

May 2013

PDF Format

Ethical Issues With Vaccination for the Obstetrician–Gynecologist

Committee Opinion Number 564, May 2013

(Reaffirmed 2016)

ABSTRACT Because of the growing importance of infectious disease prevention in the individual patient and the larger community it is vital that Fellows of the American College of Obstetricians and Gynecologists be prepared to navigate the practical and ethical challenges that come with vaccination...

May 2013

PDF Format

Improving Medication Safety

Committee Opinion Number 531, August 2012

(Reaffirmed 2016. Replaces No. 331, April 2006 and No. 400, March 2008)

ABSTRACT Despite significant national attention medical errors continue to pervade the US health care system Medicationrelated errors consistently rank at the top of all medical errors which account for thousands of preventable deaths annually in the United States There are a variety of methodsran...

August 2012

PDF Format

Influenza Vaccination During Pregnancy

Committee Opinion Number 608, September 2014

(Reaffirmed 2016. Replaces Committee Opinion Number 468, October 2010)

ABSTRACT The Centers for Disease Control and Preventions Advisory Committee on Immunization Practices and the American College of Obstetricians and Gynecologists recommend that all adults receive an annual influenza vaccine Influenza vaccination is an essential element of preconception prenatal an...

September 2014

PDF Format

Integrating Immunizations Into Practice

Committee Opinion Number 661, April 2016

ABSTRACT Immunization against vaccinepreventable diseases is an essential component of womens primary and preventive health care Despite the importance of vaccination and clear guidance from public health agencies rates of vaccination lag behind national goals Obstetriciangynecologists can play a ...

April 2016

PDF Format

Labor Induction or Augmentation and Autism

Committee Opinion Number 597, May 2014

(Reaffirmed 2016)

Abstract Functional oxytocin deficiency and a faulty oxytocin signaling pathway have been observed in conjunction with autism spectrum disorder ASD Because exogenous synthetic oxytocin commonly is administered for labor induction and augmentation some have hypothesized that synthetic oxytocin used...

May 2014

PDF Format

Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection

Committee Opinion Number 455, March 2010

Reaffirmed 2015

Abstract Numerous large clinical studies have evaluated the evidence regarding magnesium sulfate neuroprotection and preterm births The Committee on Obstetric Practice and the Society for MaternalFetal Medicine recognize that none of the individual studies found a benefit with regard to their prim...

March 2010

PDF Format

Magnesium Sulfate Use in Obstetrics

Committee Opinion Number 652, January 2016

(Reaffirmed 2016. Replaces Committee Opinion Number 573, September 2013)

ABSTRACT The US Food and Drug Administration advises against the use of magnesium sulfate injections for more than 57 days to stop preterm labor in pregnant women Based on this the drug classification was changed from Category A to Category D and the labeling was changed to include this new warnin...

January 2016

PDF Format

Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women

Committee Opinion Number 557, April 2013

(Reaffirmed 2015)

ABSTRACT Initial evaluation of the patient with acute abnormal uterine bleeding should include a prompt assessment for signs of hypovolemia and potential hemodynamic instability After initial assessment and stabilization the etiologies of acute abnormal uterine bleeding should be classified using ...

April 2013

PDF Format

Misoprostol for Postabortion Care

Committee Opinion Number 427, February 2009

ABSTRACT The World Health Organization estimates that 67000 women mostly in developing countries die each year from untreated or inadequately treated abortion complications Postabortion care a term commonly used by the international reproductive health community refers to a specific set of service...

February 2009

PDF Format

Nalbuphine Hydrochloride Use for Intrapartum Analgesia

Committee Opinion Number 376, August 2007

(Reaffirmed 2014)

ABSTRACT Safety concerns have been raised regarding the use of nalbuphine hydrochloride during labor The American College of Obstetricians and Gynecologists finds data are insufficient to recommend any changes in nalbuphine hydrochloride administration at this time Opinion Nalbuphine hydrochloride...

August 2007

PDF Format

Nonmedical Use of Prescription Drugs

Committee Opinion Number 538, October 2012

Reaffirmed 2014

ABSTRACT The nonmedical use of prescription drugs particularly opioids sedatives and stimulants has been cited as epidemic in the United States accounting for increasing numbers of emergency department visits and deaths from reactions and overdoses The prevalence of prescription drug abuse is simi...

October 2012

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998